B. BRAUN 0.3% SODIUM CHLORIDE & 3.3% GLUCOSE IV INFUSION BP (1000ML)

Country: Malaysia

Language: English

Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Active ingredient:

Glucose monohydrate; SODIUM CHLORIDE (SALT)

Available from:

B.BRAUN MEDICAL INDUSTRIES SDN BHD

INN (International Name):

Glucose monohydrate; SODIUM CHLORIDE (SALT)

Units in package:

1000ml mL

Manufactured by:

B.BRAUN MEDICAL INDUSTRIES SDN BHD

Summary of Product characteristics

COMPOSITION
Each 100 ml contains:
Sodium Chloride
0.30 g
Glucose Monohydrate for Parenteral Use
3.63 g
Water for Injections to
100 ml
Electrolytes:
mmol/l (mEq/l)
Na
+
51
Cl
-
51
Caloric value:
553 kJ/l  132 kcal/l
Osmolarity:
286 mOsm/l
CHARACTERISTICS
B. BRAUN 0.3% SODIUM CHLORIDE AND 3.3%
GLUCOSE
INTRAVENOUS
INFUSION
represents
an
isotonic I.V. solution. The outstanding feature of
this solution is the markedly low electrolyte con-
tent which makes it particularly suitable for use
in case of hypertonic dehydration.
MECHANISMS OF ACTION
Glucose
is
absorbed
from
the
gastrointesti-
nal tract, and oxidised as a souree of energy,
or stored in the liver as glyeogen. It is the only
energy substrate which is directly, instantly and
universally utilized by the body. Glucose is vital
for the myocardium, brain and nerves.
Sodium Chloride is the principal salt involved in
maintaining the osmotic tension of the blood
and tissue. Changes in sodium and chloride levels
change this osmotic tension and hence influenee
the movement of fluids and diffusion of salts in
cellular tissue.
INDICATIONS
Hypertonic (especially hypernatremic) dehydration
Supply of free water,
Caloric supply,
Vehicle solution for supplementary medication.
DOSAGE
According to individual requirements approxi-
mately 1000 ml/day
Drop rate: up to 120-180 drops/min correspond-
ing to 360-540 ml/h
ROUTE OF ADMINISTRATION I.V.
CONTRAINDICATIONS
Hyperhydration, oedema
Hypotonic dehydration
Cardiac insufficiency
Diabetes mellitus.
PRECAUTIONS
Use with caution in patients with hypertension
and diabetes mellitus. Blood glucose, serum elec-
trolytes and water balance should be monitored
regularly.
The compatibility of any additives to this solution
should be checked before use.
SIDE EFFECTS
Hyperglycaemia
and
glucosuria
may
occur
if
glucose
tolerance
is
impaired.
These
can
be
avoided by reducing the dosage and infusion rate
or by administering insulin.
SYMPTOMS AND TREATMENT FOR OVERDOSAGE
If hyperglycaemia or glucosuria occur, the dosage
and infusion rate should be